Bora Janicijevic
Family Medicine · Mt Lebanon, PANPI 1942526660
Payments from drug & device makers
Across 397 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- AbbVie$963
- AstraZeneca$909
- Amgen$801
- Pfizer$712
- Abbott$369
- plus $1K from 20 others
What the payments were for
- Food & beverage$6,638100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 91 | $1,477 |
| AbbVie(2 entities) | 59 | $963 |
| AstraZeneca | 47 | $909 |
| Amgen | 53 | $801 |
| Pfizer | 44 | $712 |
| Abbott | 20 | $369 |
| Novo Nordisk | 16 | $305 |
| Merck | 14 | $221 |
| Lilly USA, LLC | 11 | $189 |
| Teva Pharmaceuticals USA, Inc. | 8 | $110 |
| Genentech USA, Inc. | 5 | $92 |
| Biohaven Pharmaceuticals, Inc. | 5 | $80 |
| Esperion Therapeutics, Inc. | 3 | $63 |
| Exact Sciences | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Seqirus USA Inc | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Boehringer Ingelheim | 2 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $21 |
| Mission Pharmacal Company | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $16 |
| Bausch Health US, LLC | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$105
How this compares
$6,644 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 100 | $119,143 |
| OzempicSemaglutide | 68 | $83,158 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 68 | $74,171 |
| Repatha SureclickEvolocumab | 28 | $33,219 |
| TradjentaLinagliptin | 33 | $31,015 |
| XareltoRivaroxaban | 23 | $23,600 |
| JanuviaSitagliptin Phosphate | 18 | $17,565 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $15,830 |
| FarxigaDapagliflozin Propanediol | 21 | $15,752 |
| Sucralfate | 47 | $13,243 |
| MounjaroTirzepatide | 11 | $10,828 |
| JardianceEmpagliflozin | 16 | $10,112 |
| Emgality PenGalcanezumab-Gnlm | 12 | $9,299 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 66 | $8,711 |
| Atorvastatin Calcium | 466 | $4,196 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $712 | $119,143100 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $1,477 | $90,00190 claims |
| Novo NordiskOzempic | $305 | $83,15868 claims |
| Boehringer IngelheimTradjenta, Jardiance | $24 | $41,12849 claims |
| MerckJanuvia | $221 | $17,56518 claims |
| AstraZenecaFarxiga | $909 | $15,75221 claims |
| Lilly USA, LLCMounjaro | $189 | $10,82811 claims |
| AbbVieSynthroid | $963 | $2,16025 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Mt Lebanon
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.